Hepatitis C Virus Epidemiology, Pathogenesis, Diagnosis, and Natural History

  • Author: Francesco Negro, MD (More Info)
  • Editors In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 5/23/18 (What's New)

Summary

  • Current CDC (Management Guidelines),[CDC Chronic HCV]  US Preventive Services Task Force (Management Guidelines),[USPSTF Screening] and AASLD-IDSA guidelines (Management Guidelines)[AASLD-IDSA HCV] recommend that all adults born between 1945 and 1965 receive 1-time testing for HCV infection without previous ascertainment of HCV risk
    • Click here to view a Video Insight in which John W. Ward, MD, discusses the background to the updated birth cohort screening guidance from the CDC
  • Anti-HCV screening in other populations should be based on risk assessment, with 1-time HCV testing recommended for all individuals with the following behaviors, conditions, or exposures associated with elevated risk of HCV infection[AASLD-IDSA HCV]:

    Action required

    Keywords: Hepatitis C, Hepatitis C-Diagnosis, Hepatitis C-Screening

    ©2018 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.